Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus

Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus

The emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus closely related to SARS-CoV and officially known as <i>Betacoronavirus pandemicum</i> precipitated a substantial surge in vaccine development that culminated during the global COVID-19 pandemic. A...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sofia M. Gulova, Uliana S. Veselkina, Irina V. Astrakhantseva
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Vaccines
Subjects:	SARS-CoV-2 vaccine viral evolution pan-coronavirus vaccine viral variants immune evasion
Online Access:	https://www.mdpi.com/2076-393X/13/7/761
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

From Wuhan to Omicron K.P2 strain: A comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine
by: Adewunmi Akingbola, et al.
Published: (2025-12-01)

Pan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes
by: Masaud Shah, et al.
Published: (2025-04-01)

Identification of Clinical and Genomic Features Associated with SARS-CoV-2 Reinfections
by: Francisco Muñoz-López, et al.
Published: (2025-06-01)

Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
by: Hongjie Xia, et al.
Published: (2023-12-01)

A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variants
by: Hawa Vahed, et al.
Published: (2025-12-01)

Phylodynamic analysis revealed that human mobility and vaccination were correlated to the local spread of SARS-CoV-2 in Republic of Korea
by: Sangyi Lee, et al.
Published: (2023-12-01)

Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
by: Guilherme Dias de Melo, et al.
Published: (2021-07-01)

Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants
by: Mohamed Mahdi, et al.
Published: (2025-05-01)

SARS-CoV-2 infection of domestic animals and their role in evolution and emergence of variants of concern
by: Olajumoke Olufunmilayo Joseph, et al.
Published: (2024-12-01)

Recent Advances in Designing Adeno-Associated Virus-Based Vaccines Against Viral Infections
by: Njabulo Mnyandu, et al.
Published: (2024-10-01)

An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
by: Fábio Mambelli, et al.
Published: (2025-01-01)

Secondary structure of the SARS-CoV-2 genome is predictive of nucleotide substitution frequency
by: Zach Hensel
Published: (2025-02-01)

Second-Generation Phage Lambda Platform Employing SARS-CoV-2 Fusion Proteins as a Vaccine Candidate
by: Alexis Catala, et al.
Published: (2024-10-01)

Comparative Epidemiological and Clinical Outcomes on COVID-19 and Seasonal Influenza Hospitalized Patients during 2023
by: Constantin-Marinel Vlase, et al.
Published: (2024-08-01)

Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice
by: William Becker, et al.
Published: (2024-11-01)

Tolerance of Inactivated SARS-CoV-2 Vaccine for People Living with HIV: A Real-World Evidence Analysis from a Retrospective Cohort Study
by: Qian He, et al.
Published: (2025-08-01)

Correlation of patient symptoms with SARS-CoV-2 Omicron variant viral loads in nasopharyngeal and saliva samples and their influence on the performance of rapid antigen testing
by: Kenichiro Shiraishi, et al.
Published: (2024-11-01)

Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives
by: Yu-An Kung, et al.
Published: (2025-07-01)

Fixation and reversion of mutations in the receptor-binding domain of the SARS-CoV-2 spike protein: A 2020–2024 analysis
by: Daniele Focosi, et al.
Published: (2024-12-01)

Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 Vaccination
by: Nicholas Bbosa, et al.
Published: (2024-11-01)

The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications
by: Alaa A. A. Aljabali, et al.
Published: (2025-07-01)

Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination
by: Yuxin Chen, et al.
Published: (2021-01-01)

An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV
by: Hailong Guo, et al.
Published: (2023-12-01)

High diversity in Delta variant across countries revealed by genome‐wide analysis of SARS‐CoV‐2 beyond the Spike protein
by: Rohit Suratekar, et al.
Published: (2022-02-01)

Identification of SARS-CoV-2 variants of concern in vaccine-breakthrough infections
by: Baha Abdalhamid, et al.
Published: (2022-04-01)

Induction of significant neutralizing antibodies against SARS-CoV-2 by a highly attenuated pangolin coronavirus variant with a 104nt deletion at the 3'-UTR
by: Shanshan Lu, et al.
Published: (2023-12-01)

Neutralizing antibody responses to SARS-CoV-2 variants after COVID-19 vaccination and boosters
by: Kabita Adhikari, et al.
Published: (2025-06-01)

The role of intrinsically disordered regions of SARS-CoV-2 nucleocapsid and non-structural protein 1 proteins
by: Getasew Shitaye, et al.
Published: (2025-06-01)

A comprehensive immune repertoire signature distinguishes pulmonary infiltration in SARS-CoV-2 Omicron variant infection
by: Xuechuan Li, et al.
Published: (2024-12-01)

The effect of SARS-CoV-2 and influenza vaccination on endemic coronavirus-related mortality: A retrospective cohort study in Brazil
by: Char Leung, et al.
Published: (2025-12-01)

Immunogenicity of monovalent and multivalent subunit vaccines against SARS-CoV-2 variants in mice with divergent vaccination history
by: Rui Wang, et al.
Published: (2025-08-01)

Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough
by: Yichuan Yao, et al.
Published: (2025-01-01)

Assessment of COVID-19 Vaccine Effectiveness Against SARS-CoV-2 Infection, Hospitalization and Death in Mexican Patients with Metabolic Syndrome from Northeast Mexico: A Multicenter Study
by: Beatriz Silva Ramírez, et al.
Published: (2025-02-01)

Integrated Analysis of the 2022 SARS-CoV-2 Omicron Lineage Replacement Dynamics in Connecticut, US
by: Nicholas F. G. Chen, et al.
Published: (2025-07-01)

Evaluation of the relationship between progression and SARS-CoV-2 viral load in COVID-19 cases in Ankara, Turkey
by: Mustafa Guney, et al.
Published: (2022-03-01)

Rates of SARS-CoV-2 Breakthrough Infection or Severe COVID-19 and Associated Risk Factors After Primary and Booster Vaccination Against COVID-19 in the Netherlands
by: Jesse M. van den Berg, et al.
Published: (2025-05-01)

Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination
by: Nungruthai Suntronwong, et al.
Published: (2023-12-01)

Combining Short- and Long-Read Sequencing Technologies to Identify SARS-CoV-2 Variants in Wastewater
by: Gabrielle Jayme, et al.
Published: (2024-09-01)

COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
by: Ilker Polatoğlu, et al.
Published: (2023-04-01)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Mohamed, Moubarak, et al.
Published: (2023)